Aarey Drugs (India) Today
| AAREYDRUGS | 58.17 0.21 0.36% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Aarey Drugs is selling at 58.17 as of the 29th of November 2024; that is 0.36 percent increase since the beginning of the trading day. The stock's lowest day price was 57.0. Aarey Drugs has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Aarey Drugs Pharmaceuticals are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 31st of August 2024 and ending today, the 29th of November 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Aarey Drugs is entity of India. It is traded as Stock on NSE exchange. The company has 28.35 M outstanding shares. More on Aarey Drugs Pharmaceuticals
Moving together with Aarey Stock
Moving against Aarey Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Aarey Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Aarey Drugs' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Aarey Drugs or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Thematic Idea | Drugs (View all Themes) | ||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Drugs, Health Care, Pharmaceuticals, Drug Manufacturers-Specialty & Generic, Healthcare (View all Sectors) | ||||
Aarey Drugs' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Aarey Drugs' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsAarey Drugs can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Aarey Drugs' financial leverage. It provides some insight into what part of Aarey Drugs' total assets is financed by creditors.
| |||||
Aarey Drugs Pharmaceuticals (AAREYDRUGS) is traded on National Stock Exchange of India in India and employs 8 people. Aarey Drugs is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.73 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Aarey Drugs's market, we take the total number of its shares issued and multiply it by Aarey Drugs's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Aarey Drugs Pharmace operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 28.35 M outstanding shares.
Aarey Drugs generates negative cash flow from operations
Check Aarey Drugs Probability Of Bankruptcy
Ownership AllocationAarey Drugs holds a total of 28.35 Million outstanding shares. Aarey Drugs Pharmaceuticals retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Aarey Ownership Details
Aarey Drugs Pharmace Risk Profiles
Although Aarey Drugs' alpha and beta are two of the key measurements used to evaluate Aarey Drugs' performance over the market, the standard measures of volatility play an important role as well.
Aarey Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Aarey Drugs without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Companies Directory Now
Companies DirectoryEvaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |
| All Next | Launch Module |
Aarey Drugs Corporate Management
Elected by the shareholders, the Aarey Drugs' board of directors comprises two types of representatives: Aarey Drugs inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Aarey. The board's role is to monitor Aarey Drugs' management team and ensure that shareholders' interests are well served. Aarey Drugs' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Aarey Drugs' outside directors are responsible for providing unbiased perspectives on the board's policies.
| A Kathawala | Chief Accountant | Profile | |
| Milind Churi | Head Production | Profile | |
| Mihir BE | Chairman MD | Profile | |
| J Gohil | Head Plant | Profile | |
| Preeti Rathi | Company Officer | Profile | |
| Mira Ghatalia | Chief Officer | Profile |
Additional Tools for Aarey Stock Analysis
When running Aarey Drugs' price analysis, check to measure Aarey Drugs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aarey Drugs is operating at the current time. Most of Aarey Drugs' value examination focuses on studying past and present price action to predict the probability of Aarey Drugs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aarey Drugs' price. Additionally, you may evaluate how the addition of Aarey Drugs to your portfolios can decrease your overall portfolio volatility.